PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MiMedx Group, Inc. (MDXG)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US6024961012

CUSIP

602496101

Sector

Healthcare

IPO Date

Aug 22, 2007

Highlights

Market Cap

$1.41B

EPS (TTM)

$0.57

PE Ratio

16.88

PEG Ratio

2.97

Total Revenue (TTM)

$255.97M

Gross Profit (TTM)

$212.43M

EBITDA (TTM)

$49.64M

Year Range

$5.47 - $10.14

Target Price

$13.40

Short %

3.27%

Short Ratio

3.53

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
MDXG vs. SPY
Popular comparisons:
MDXG vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in MiMedx Group, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
29.19%
5.05%
MDXG (MiMedx Group, Inc.)
Benchmark (^GSPC)

Returns By Period

MiMedx Group, Inc. had a return of -8.00% year-to-date (YTD) and 10.21% in the last 12 months. Over the past 10 years, MiMedx Group, Inc. had an annualized return of -0.46%, while the S&P 500 had an annualized return of 11.24%, indicating that MiMedx Group, Inc. did not perform as well as the benchmark.


MDXG

YTD

-8.00%

1M

-7.52%

6M

29.20%

1Y

10.21%

5Y*

4.73%

10Y*

-0.46%

^GSPC (Benchmark)

YTD

0.62%

1M

-2.22%

6M

5.05%

1Y

24.42%

5Y*

12.67%

10Y*

11.24%

*Annualized

Monthly Returns

The table below presents the monthly returns of MDXG, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-11.74%5.43%-5.64%-20.00%16.07%-3.08%7.50%-8.19%-13.60%15.91%35.04%4.00%9.69%
202339.21%24.29%-29.11%12.32%53.00%12.80%22.09%-8.05%-1.75%-10.01%18.45%12.87%215.47%
2022-17.88%1.81%-6.73%-16.14%-1.01%-11.25%-1.44%3.22%-18.70%3.14%9.80%-14.46%-53.97%
20218.15%0.92%3.94%-5.83%10.21%17.03%-2.00%20.39%-58.94%13.04%2.34%-13.84%-33.48%
2020-2.64%-12.47%-45.98%12.89%-8.88%50.42%2.59%22.74%-6.54%-16.29%26.13%35.32%19.79%
201947.21%13.85%17.00%-31.62%89.58%-10.99%29.63%-1.90%-4.85%15.71%28.57%3.98%323.46%
201832.83%-57.67%-1.69%17.79%2.56%-24.11%-33.49%24.71%16.60%-5.83%-48.28%-40.53%-85.80%
2017-8.80%6.06%11.20%33.16%7.80%9.43%-0.07%8.76%-26.98%6.73%-8.75%8.99%42.33%
2016-11.21%-1.08%6.20%-13.84%4.52%1.40%-6.14%-3.34%18.51%3.85%6.40%-6.54%-5.44%
2015-29.27%26.92%0.48%-9.62%10.11%11.98%-7.42%-9.51%-0.62%-24.56%23.08%4.58%-18.73%
2014-10.30%-8.80%-14.27%-5.71%-5.36%29.62%-2.54%1.88%1.28%42.78%8.64%4.25%31.92%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MDXG is 53, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of MDXG is 5353
Overall Rank
The Sharpe Ratio Rank of MDXG is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of MDXG is 5454
Sortino Ratio Rank
The Omega Ratio Rank of MDXG is 5151
Omega Ratio Rank
The Calmar Ratio Rank of MDXG is 5454
Calmar Ratio Rank
The Martin Ratio Rank of MDXG is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for MDXG, currently valued at 0.15, compared to the broader market-4.00-2.000.002.000.151.92
The chart of Sortino ratio for MDXG, currently valued at 0.71, compared to the broader market-4.00-2.000.002.004.000.712.57
The chart of Omega ratio for MDXG, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.35
The chart of Calmar ratio for MDXG, currently valued at 0.11, compared to the broader market0.002.004.006.000.112.86
The chart of Martin ratio for MDXG, currently valued at 0.40, compared to the broader market-10.000.0010.0020.000.4012.10
MDXG
^GSPC

The current MiMedx Group, Inc. Sharpe ratio is 0.15. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of MiMedx Group, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.15
1.92
MDXG (MiMedx Group, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


MiMedx Group, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-50.72%
-2.82%
MDXG (MiMedx Group, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the MiMedx Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MiMedx Group, Inc. was 93.84%, occurring on Mar 24, 2009. Recovery took 953 trading sessions.

The current MiMedx Group, Inc. drawdown is 50.72%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.84%Apr 1, 2008134Mar 24, 2009953Apr 29, 20131087
-93.6%Jan 30, 2018217Dec 7, 2018
-48.65%Jul 20, 2015206May 11, 2016246May 3, 2017452
-48.34%Jun 26, 201349Sep 4, 201370Dec 12, 2013119
-41.76%Jan 2, 201487May 7, 2014112Oct 15, 2014199

Volatility

Volatility Chart

The current MiMedx Group, Inc. volatility is 9.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
9.78%
4.46%
MDXG (MiMedx Group, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of MiMedx Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of MiMedx Group, Inc. compared to its peers in the Medical Devices industry.


PE Ratio
50.0100.0150.0200.016.9
The chart displays the price to earnings (P/E) ratio for MDXG in comparison to other companies of the Medical Devices industry. Currently, MDXG has a PE value of 16.9. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
-60.0-40.0-20.00.020.040.060.080.03.0
The chart displays the price to earnings to growth (PEG) ratio for MDXG in comparison to other companies of the Medical Devices industry. Currently, MDXG has a PEG value of 3.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for MiMedx Group, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab